EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudieOpen Access · CC BY 4.0

Single‐cell‐based non‐invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis

T Stampalija iD, C Forcato, F R Grati, P Volpe iD, V De Robertis iD, C Izzi, E Bertucci, I Fabietti, A Novelli iD, S Ornaghi, L Pasquini iD, E Bevilacqua iD und 12 weitere

Ultrasound in Obstetrics & Gynecology · 2026

DOI: 10.1002/uog.70201 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2026. Verfasst von T Stampalija und 23 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing, DNA Copy Number Variations, Single-Cell Analysis, Maternal Serum Screening Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pathogenic or likely pathogenic copy‐number variants (p/lpCNVs) are a significant cause of perinatal morbidity and mortality. Current prenatal screening based on cell‐free DNA (cfDNA) fails to detect the majority of microimbalances (microdeletions/microduplications), leaving a significant residual risk of undetected chromosomal abnormalities. This study evaluated the clinical performance of a novel single‐cell‐sequencing‐based non‐invasive prenatal testing (scsbNIPT) method utilizing circulating extravillous trophoblasts (cEVTs) for the detection of fetal p/lpCNVs, particularly microimbalances < 8 Mb.

Methods

This was a prospective, blinded, observational multicenter cohort study of 1390 high‐risk pregnant women undergoing prenatal invasive diagnostic testing between November 2021 and December 2023. A 20‐mL maternal blood sample was collected from each subject between 11 + 0 and 22 + 6 weeks' gestation prior to invasive sampling. cEVTs were isolated and subjected to whole‐genome sequencing, using a proprietary workflow. scsbNIPT results were compared with standard invasive prenatal diagnostic results obtained by karyotyping and/or chromosomal microarray analysis. Results scsbNIPT showed a sensitivity of 92.9% (95% CI, 76.5–99.1%) and a specificity of 98.2% (95% CI, 97.0–99.0%) for the detection of genome‐wide microimbalances measuring ≥ 300 kb to < 8 Mb. The sensitivity for p/lpCNVs ≥ 300 kb in pregnancies screened at 11 + 0 to 14 + 6 weeks was 100% (95% CI, 83.9–100%). For trisomy 21, the sensitivity of scsbNIPT was 98.0% (95% CI, 92.9–99.8%) and the specificity was 99.7% (95% CI, 99.0–99.9%).

Conclusions

This study demonstrates the scientific validity and clinical utility of scsbNIPT for the non‐invasive detection of genome‐wide fetal p/lpCNVs, particularly microimbalances, with high sensitivity and a resolution comparable to that of chromosomal microarray analysis. scsbNIPT may offer more complete screening for genome‐wide p/lpCNVs, markedly lowering the residual risk early in pregnancy compared with existing cfDNA‐based methods. © 2026 Menarini Silicon Biosystems. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive Prenatal TestingDNA Copy Number VariationsSingle-Cell AnalysisMaternal Serum Screening TestsPrenatal DiagnosisHumansFemalePregnancyProspective StudiesAdultExtravillous TrophoblastsPregnancy, High-RiskCell-Free Nucleic AcidsSensitivity and Specificity

Stichwörter der Autor:innen

DNA‐based first‐trimester screeningcirculating extravillous trophoblastclinical utilityclinically relevant CNVfetal microimbalancegenome‐wide screeningintentional screeningresidual risksingle‐cell NIPTsingle‐cell sequencing

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
  • Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Reproductive Precision Medicine Unit, Menarini Silicon Biosystems, Castel Maggiore (Bologna), Italy.
  • Fetal Medicine Unit, Di Venere Hospital, Bari, Italy.
  • Clinical Genetics Unit, ASST-Spedali Civili Brescia, Brescia, Italy.
  • Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

ORCID-Profile: T Stampalija, P Volpe, V De Robertis, A Novelli, L Pasquini, E Bevilacqua, D Paladini, A Dal Molin, E Ferrazzi

Zitieren

APA

Stampalija, T., Forcato, C., Grati, F. R., Volpe, P., De Robertis, V., Izzi, C., Bertucci, E., Fabietti, I., Novelli, A., Ornaghi, S., Pasquini, L., Bevilacqua, E., Paladini, D., Ghi, T., Lattuada, D., Dori, M., Mercatelli, D., Dal Molin, A., Buson, G., …, & Collaborators (2026). Single‐cell‐based non‐invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70201

Vancouver

Stampalija T, Forcato C, Grati FR, Volpe P, De Robertis V, Izzi C, et al. Single‐cell‐based non‐invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis. Ultrasound in Obstetrics & Gynecology. 2026. doi:10.1002/uog.70201

BibTeX
@article{Stampalija2026,
  author = {Stampalija, T and Forcato, C and Grati, F R and Volpe, P and De Robertis, V and Izzi, C and Bertucci, E and Fabietti, I and Novelli, A and Ornaghi, S and Pasquini, L and Bevilacqua, E and Paladini, D and Ghi, T and Lattuada, D and Dori, M and Mercatelli, D and Dal Molin, A and Buson, G and Bolognesi, C and Doffini, A and Musci, T J and Ferrazzi, E and Collaborators, Collaborators},
  title = {Single‐cell‐based non‐invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  doi = {10.1002/uog.70201}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche